Prediction of Cytochrome P450 Substrates Using the Explainable Multitask Deep Learning Models

被引:0
|
作者
Fang, Jiaojiao [1 ]
Tang, Yan [1 ]
Gong, Changda [1 ]
Huang, Zejun [1 ]
Feng, Yanjun [1 ]
Liu, Guixia [1 ]
Tang, Yun [1 ]
Li, Weihua [1 ]
机构
[1] East China Univ Sci & Technol, Shanghai Frontiers Sci Ctr Optogenet Tech Cell Met, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
CLASSIFICATION; METABOLISM; GENERATION; INHIBITORS; DATABASE; ENZYMES; TOOL;
D O I
10.1021/acs.chemrestox.4c00199
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochromes P450 (P450s or CYPs) are the most important phase I metabolic enzymes in the human body and are responsible for metabolizing similar to 75% of the clinically used drugs. P450-mediated metabolism is also closely associated with the formation of toxic metabolites and drug-drug interactions. Therefore, it is of high importance to predict if a compound is the substrate of a given P450 in the early stage of drug development. In this study, we built the multitask learning models to simultaneously predict the substrates of five major drug-metabolizing P450 enzymes, namely, CYP3A4, 2C9, 2C19, 2D6, and 1A2, based on the collected substrate data sets. Compared to the single-task model and conventional machine learning models, the multitask fingerprints and graph neural networks model achieved superior performance with the average AUC values of 90.8% on the test set. Notably, the multitask model demonstrated its good performance on the small amount of substrate data sets such as CYP1A2, 2C9, and 2C19. In addition, the Shapley additive explanation and the attention mechanism were used to reveal specific substructures associated with P450 substrates, which were further confirmed and complemented by the substructure mining tool and the literature.
引用
收藏
页码:1535 / 1548
页数:14
相关论文
共 50 条
  • [21] Effect of Sarizotan on a cocktail of cytochrome P450 substrates
    Krösser, S
    Neugebauer, R
    Dolgos, H
    Kovar, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1196 - 1196
  • [22] In silico prediction of cytochrome P450 inhibitors
    Refsgaard, Hanne H. F.
    Jensen, Berith F.
    Christensen, Inge Thoger
    Hagen, Nina
    Brockhoff, Per B.
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (05) : 417 - 429
  • [23] Xenobiotics: Substrates and inhibitors of the plant cytochrome P450
    Michel Schalk
    Marie-Agnès Pierrel
    Alfred Zimmerlin
    Yannick Batard
    Francis Durst
    Danièle Werck-Reichhart
    Environmental Science and Pollution Research, 1997, 4 : 229 - 234
  • [24] Modified fatty acids as cytochrome P450 substrates
    De Voss, JJ
    Cryle, MJ
    Hayes, PY
    Proceedings of the 14th International Conference on Cytochromes P450: Biochemistry, Biophysics, and Bioinformatics, 2005, : 109 - 114
  • [25] The expression and substrates specificity of adrenal cytochrome P450
    Peng, RX
    Wang, H
    Zhang, YH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R418 - R418
  • [26] Xenobiotics: Substrates and inhibitors of the plant cytochrome P450
    Schalk, M
    Pierrel, MA
    Zimmerlin, A
    Batard, Y
    Durst, F
    WerckReichhart, D
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 1997, 4 (04) : 229 - 234
  • [27] Electronic models for cytochrome P450 oxidations
    Korzekwa, KR
    Grogan, J
    DeVito, S
    Jones, JP
    BIOLOGICAL REACTIVE INTERMEDIATES V: BASIC MECHANISTIC RESEARCH IN TOXICOLOGY AND HUMAN RISK ASSESSMENT, 1996, 387 : 361 - 369
  • [28] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [29] ESTABLISHMENT OF IN SILICO PREDICTION MODELS FOR CYTOCHROME P450 INDUCTIONS IN HUMAN HEPATOCYTES USING AZOLE COMPOUNDS
    Nagai, Mika
    Yoshinari, Kouichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S50 - S51
  • [30] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017